Correlation Between Rallybio Corp and Sonnet Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rallybio Corp and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rallybio Corp and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rallybio Corp and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Rallybio Corp and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rallybio Corp with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rallybio Corp and Sonnet Biotherapeutics.

Diversification Opportunities for Rallybio Corp and Sonnet Biotherapeutics

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rallybio and Sonnet is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Rallybio Corp and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Rallybio Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rallybio Corp are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Rallybio Corp i.e., Rallybio Corp and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Rallybio Corp and Sonnet Biotherapeutics

Given the investment horizon of 90 days Rallybio Corp is expected to generate 0.3 times more return on investment than Sonnet Biotherapeutics. However, Rallybio Corp is 3.37 times less risky than Sonnet Biotherapeutics. It trades about 0.12 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.1 per unit of risk. If you would invest  59.00  in Rallybio Corp on September 13, 2025 and sell it today you would earn a total of  18.00  from holding Rallybio Corp or generate 30.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.48%
ValuesDaily Returns

Rallybio Corp  vs.  Sonnet Biotherapeutics Holding

 Performance 
       Timeline  
Rallybio Corp 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Rallybio Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Rallybio Corp sustained solid returns over the last few months and may actually be approaching a breakup point.
Sonnet Biotherapeutics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors.

Rallybio Corp and Sonnet Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rallybio Corp and Sonnet Biotherapeutics

The main advantage of trading using opposite Rallybio Corp and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rallybio Corp position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.
The idea behind Rallybio Corp and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years